New FDA letters by email
One digest with new drug, medical-device and biologics letters. At most one email per day. No new letters, no email.
Confirm your email to subscribe. Unsubscribe at any time.
Last checked: Oct 1, 2026 at 19:34 UTC. Latest FDA posting included: Sep 29, 2026.
1,654 letters in the saved dataset.
1,654 letters to drug, device and biologics makers since 2021. These counts cover the full dataset; interactive filters apply after the charts load.
| Product type | Letters |
|---|---|
| Drugs | 1,312 |
| Medical Devices | 259 |
| Biologics | 83 |
| Year issued | Letters |
|---|---|
| 2021 | 262 |
| 2022 | 230 |
| 2023 | 234 |
| 2024 | 246 |
| 2025 | 406 |
| 2026 | 276 |
| Most cited sections and clauses in extracted findings | Letters |
|---|---|
| 21 CFR 211.84 | 246 |
| 21 CFR 211.100 | 203 |
| 21 CFR 211.165 | 164 |
| 21 CFR 211.192 | 152 |
| 21 CFR 211.22 | 125 |
The whole record at a glance. Set a filter on the left and your slice draws over it, then pick a tab to go deeper.
Warning letters issued per month to drug, device and biologics makers, Jan 2021 to Sep 2026. Peak: 96 in Sep 2025. Dashed line: 12-month average, now 32.0 a month. Full months only. Hover the chart for any month.
Sections and clauses with the largest comparable count changes.
The CFR sections and ISO clauses cited in the most letters. Click one to filter.
What went wrong, as read from the findings. Click one to filter.
The bigger the word, the more letters in your filter use it. Click words to filter; picking several finds letters that mention all of them.
Citations are pulled from the letter text. When a filter is on, the dim bar behind each value is the unfiltered total.
QMSR took effect February 2, 2026. Related device citations are grouped by topic. Exact references remain available; grouping does not make requirements equivalent.
Letters citing each CFR section or ISO clause in a stated finding, by year. Change compares two periods of your choosing; both counts are shown in every row. Click a row to filter.
Letters citing each section. Click a bar to filter; "Details" opens the regulation and its letters.
The most common violation statement for each section, with how many letters state it. Click a statement to read it in full; click the section number to filter.
Model-assisted issue types group the letters by quality topic. Supporting FDA passages appear in letter details where available. A letter counts once per type. Click a bar to filter.
The same filter from more angles.
Size by letters shows exact CFR sections and ISO clauses. Size by change groups related device references into topics; new-only and non-comparable topics are excluded. A line joins references found in the same letter. Counts are citation patterns, not regulatory equivalence or industry-wide compliance.
Letters by the state of the addressed facility. Brighter is more. Click a state to filter.
The same counts, ranked. Click a bar to filter.
Country of the addressed facility. Click a bar to filter.
Of each year's letters, how many went to a facility in another country. Click a year to filter.
Issue date of the letter. The latest quarter is partial. Click a column to filter to that year.
Letters issued per month. Brighter is busier.
Share of letters with a published close-out letter. Recent years are still open. Click a year to filter.
Days from the end of the inspection to the date on the letter. Each dot is a letter; the tick is the median. Only letters that state both dates.
Days from the letter to the published close-out, for the letters that have one. Recent years are censored: most are still open.
Field inspection divisions roll up to the Office of Inspections and Investigations.
Derived from FDA's subject line. A letter can carry more than one.
Product family, to the center that issued the letter, to the primary theme. Ribbon width is letters.
Median words. Longer letters carry more findings.
How many stated findings a letter carries, by product family.
Median (b)(4) redactions per 1,000 words, by issuing center.
Each letter is a dot on its date. Click a dot to open the letter.
Every letter in the current filter with sortable columns. Click a row to open it in the panel.
| Date | Company | Product | Issuing center | Themes | Cited sections | Findings | Status |
|---|
One digest with new drug, medical-device and biologics letters. At most one email per day. No new letters, no email.
Confirm your email to subscribe. Unsubscribe at any time.
This snapshot combines FDA index fields, rule-extracted CFR and explicit ISO 13485 citations and findings, and model-assisted issue types, requests and prose findings. Exact ISO clauses and CFR sections remain separate. The versioned device-topic map groups related citations for navigation and comparison; it is editorial grouping, not regulatory equivalence. Top-level descriptions use source excerpts checked against the archived FDA letter, not unchecked AI summaries. These selected passages do not summarize the entire letter. Finding interpretations and categories still require source review. Response timing appears only when supported by verified response wording; a published close-out status does not establish a firm's current compliance.
Coverage is limited to the letters retained in this saved snapshot. Missing letters or close-out records should not be interpreted as a firm's current regulatory status.